Purchase Order 36C26222P1419
Award Date
9/1/22
Potential Completion Date
8/31/23
Potential Value
$7.3K
Federal Agency
Veterans Integrated Service Network 22
Awardee
Fulgent Therapeutics LLC
Ultimate Awardee
Fulgent Genetics, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tucson, AZ 85723, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded Fulgent Therapeutics LLC a $3.2 million firm fixed price delivery order against its Medical Laboratory Testing and Analysis Services GSA Schedule contract. Fulgent Therapeutics, doing business as Fulgent Diagnostics and a division of Fulgent Genetics, will provide COVID-19 cost per test services to VHA's Veterans Integrated Service Network 21 through December 2020. The contract supports VHA's coronavirus disease testing...
This is a federal contract award from the Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The $2,300,000 firm fixed-price delivery order is for germline pharmacogenomic molecular testing services, with a period of performance through September 30, 2025. The contract is part of a larger $99,032,828.20 multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the VA Strategic...
This is a firm fixed price definitive contract awarded by the Veterans Integrated Service Network 17 of the Department of Veterans Affairs to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for $1,010,000.00 and has a period of performance through September 30, 2028. The contract is for genetics testing services, including clinical genetic testing, germline genetic testing utilizing whole genome sequencing, custom gene...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for germline genetic testing services. The contract has a ceiling value of $95,817.89 and a period of performance through September 30, 2018. It was awarded as a total small business set-aside. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits and services to various federal agencies, including the VA,...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for $201,500 to provide clinical genetic testing services for chronic kidney disease. The contract has a performance period through January 17, 2024. Fulgent Diagnostics is a division of Fulgent Genetics, Inc., which specializes in genetic and genomic testing services for the federal government, including the VA,...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a provider of genomic testing services and COVID-19 testing kits and services to U.S. federal government agencies. The contract is for germline genetic testing with a potential value of $150,000.00 and is a Firm Fixed Price BPA Call order. Fulgent Therapeutics holds a separate $950,000.00 Blanket Purchase Agreement from...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for the delivery of laboratory testing kits, with a ceiling value of $889,097.43 and a period of performance through December 30, 2024. There was no set-aside designation used for this award. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits...
The Department of Veterans Affairs awarded a $252,386.34 firm-fixed-price definitive contract to Ameripath Inc., a subsidiary of Quest Diagnostics Incorporated, for reference laboratory testing services. The contract, which has no set-aside designation, covers urgent anatomic pathology testing, including processing renal biopsy specimens and providing consultations for the Southern Arizona Veterans Affairs Healthcare System in Tucson, Arizona. The contract has a base year and four one-year...
This is a $101,612.61 firm-fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Ameripath Inc. Dermpath Diagnostics Division, a subsidiary of Quest Diagnostics Incorporated. The contract is for reference laboratory testing services, including processing and analyzing patient specimens, providing consultations on prepared pathology slides, and offering dermatopathology services to support the Southern Arizona Veterans Affairs Healthcare System (SAVAHCS) in Tucson,...
This federal contract award for $208,537.65 was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 22 to Ameripath Inc., a subsidiary of Quest Diagnostics Incorporated, to provide dermatopathology testing services for the Southern Arizona Veterans Affairs Healthcare System in Tucson, Arizona. The contract was awarded on a firm-fixed-price basis and does not have a set-aside designation. It covers dermatopathology consultations, specimen processing, and courier...